Home > About ALF > Policies > Medical Policies > HCV Screening Recommendations from US Preventative Services Task Force
- Liver Diseases
- Overview
- Alcohol-Associated Liver Disease
- Autoimmune Liver Diseases
- Cancer
- Complications of Liver Disease
- Diagnosing Liver Disease
- Fatty Liver Disease (Steatotic Liver Disease)
- Pediatric Liver Information Center
- Overview
- Pediatric Liver Disease
- Alagille Syndrome
- Alpha-1 Antitrypsin Deficiency
- Autoimmune Liver Disease in Children
- Biliary Atresia
- Budd-Chiari Syndrome
- Crigler-Najjar Syndrome
- Galactosemia
- Hepatitis B
- Hepatitis C in Children
- Nonalcoholic Fatty Liver Disease (NAFLD) in Children
- Glycogen Storage Disease Type 1 (von Gierke)
- Primary Sclerosing Cholangitis (PSC) in Children
- Progressive Familial Intrahepatic Cholestasis (PFIC)
- Gilbert Syndrome
- Reye's Syndrome
- Wilson Disease
- Parents
- Liver Disease for Teen and Young Adults
- Kids
- Bili the Brave™ Toolkit
- Video Library
- Liver Terminology
- Rare Disease
- Treatment
- Viral Hepatitis
- About Your Liver
- Health and Wellness
- Resource Center
- How You Can Help
- About ALF
- Mission, Impact and History
- Research Awards Program
- People
- Financial Information
- Policies
- Corporate Policies
- Medical Policies
- COVID-19 Alert Policy
- HCV Screening Recommendations from US Preventative Services Task Force
- Hepatitis A Policy
- Hepatitis C Testing Policy
- Incarcerated Persons
- Needle Exchange Policy
- Organ Donation Policy
- Position on the Use and Care of Animals in Research
- Position Statement on Hepatitis A and Vaccination
- Careers
- Contact Us
Hepatitis C Virus Infection in Adolescents and Adults: Screening
Recommendations made by the USPSTF are independent of the U.S. government. They should not be construed as an official position of the Agency for Healthcare Research and Quality or the U.S. Department of Health and Human Services. To read and download the full position statement, visit the USPSTF web page.
Last updated on September 18th, 2023 at 10:33 am